Detalles de la búsqueda
1.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838010
2.
Cell-cycle inhibition and immune microenvironment in breast cancer treated with ribociclib and letrozole or chemotherapy.
NPJ Breast Cancer
; 10(1): 20, 2024 Mar 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38448600
3.
Comparison of ultrasound guided surgery and radio-guided occult lesions localization (ROLL) for nonpalpable breast cancer excision.
Gland Surg
; 12(9): 1233-1241, 2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37842539
4.
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis.
Cancer Discov
; 12(12): 2754-2762, 2022 12 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36255231
5.
When Is Sentinel Node Biopsy Indicated in High-Risk Ductal Carcinoma in situ? Four Hundred Sixty-Eight Cases from Three Institutions.
Breast Care (Basel)
; 16(6): 630-636, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35087365
6.
Efficacy and Determinants of Response to HER Kinase Inhibition in HER2-Mutant Metastatic Breast Cancer.
Cancer Discov
; 10(2): 198-213, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31806627
7.
Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
Eur J Cancer
; 58: 122-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26994459
8.
The Peony trial: adding evidence to pertuzumab use in non-metastatic breast cancer.
Gland Surg
; 9(4): 1086-1089, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32953622
9.
Inference of tumor evolution during chemotherapy by computational modeling and in situ analysis of genetic and phenotypic cellular diversity.
Cell Rep
; 6(3): 514-27, 2014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24462293
10.
Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.
Cancer Res
; 73(21): 6424-34, 2013 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24030979
11.
Giant phyllodes tumour - Case report, oncoplastic treatment and literature controversies / Tumor phyllodes gigante - Caso clínico, cirurgía oncoplástica y controversias en la literatura
Rev. senol. patol. mamar. (Ed. impr.)
; 30(2): 79-84, abr.-jun. 2017. tab, ilus
Artículo
en Inglés
| IBECS (España) | ID: ibc-163549
Resultados
1 -
11
de 11
1
Próxima >
>>